We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Collaboration Agreement for the Production of Ultra High-Field 7.0-T MRI Systems

By MedImaging International staff writers
Posted on 20 May 2015
GE Healthcare (Chalfont St. Giles, UK) and Tesla Engineering (Pulborough; England) have announced that they will collaborate to produce 7.0-T human whole-body Magnetic Resonance Imaging (MRI) scanners.

Tesla Engineering, a cryogenics technology company, designs and manufactures resistive and superconducting electromagnets, and will build the 7.0-T magnets in a new factory under construction in Storrington (UK). The company plans to ship the first 7.0-T unit to GE Healthcare in late 2015.

Researchers use the ultra-high-field MRI scanners for scientific and medical research, especially for brain imaging. The research is intended to contribute to earlier detection, better diagnosis, and improved effectiveness for many medical disorders and diseases.

Richard Hausmann, president and CEO of GE Healthcare, said, “This agreement will enable GE to deepen and broaden our collaborations with leading MRI academics and visionaries, sharing our collective expertise and missions in technology, science and medicine. The GE 7.0-T community in the US, Europe and Asia has already demonstrated breakthrough observations and understanding of Alzheimer’s disease, traumatic brain injury and cognitive physiology. Together, we will continue to push the frontiers of MRI for neuroscience and other applications.”

Related Links:

GE Healthcare
Tesla Engineering 


MRI System
nanoScan MRI 3T/7T
Computed Tomography System
Aquilion ONE / INSIGHT Edition
X-ray Diagnostic System
FDX Visionary-A
Post-Processing Imaging System
DynaCAD Prostate

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.